Molecular Targeted α-Particle Therapy for Oncologic Applications

摘要

OBJECTIVEA significant challenge facing traditional cancer therapies is their propensity to significantly harm normal tissue. The recent clinical success of targeting therapies by attaching them to antibodies that are specific to tumor-restricted biomarkers marks a new era of cancer treatments.